Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: The JALSG-ALL97 study

International Journal of Hematology

Volumn 92, Issue 3, 2010, Pages 490-502

  Jinnai, Itsuro ^a   Sakura, Tohru ^b   Tsuzuki, Motohiro ^c   Maeda, Yasuhiro ^d   Usui, Noriko ^e   Kato, Masayuki ^f   Okumura, Hirokazu ^g   Kyo, Taiichi ^h   Ueda, Yasunori ⁱ   Kishimoto, Yuji ^j   Yagasaki, Fumiharu ^a   Tsuboi, Kosuke ^k   Horiike, Shigeo ^l   Takeuchi, Jin ^m   Iwanaga, Masako ⁿ   Miyazaki, Yasushi ⁿ   Miyawaki, Shuichi ^o   Ohnishi, Kazunori ^p   Naoe, Tomoki ^q   Ohno, Ryuzo ^r  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Maebashi Saiseikai Hospital   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^h ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

ⁱ KURASHIKI CENTRAL HOSPITAL   (Japan)

^j KANSAI MEDICAL UNIVERSITY   (Japan)

^k TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^m NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^o Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^p HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^r AICHI SHUKUTOKU UNIVERSITY   (Japan)

more..

Author keywords

A multiinstitutional trial; Acute lymphoblastic leukemia; Doxorubicin; Prognostic factors; The Japan Adult Leukemia Study Group (JALSG)

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADULT DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CONTINUOUS INFUSION; CYTOGENETICS; DISEASE FREE SURVIVAL; DRUG DOSE ESCALATION; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JAPAN; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 78549295157     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0672-z     Document Type: Article

References (29)

1. BJ Druker CL Sawyers H Kantarjian DJ Resta SF Reese JM Ford, et al. 2001 Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 1038 1042 1:CAS:528: DC%2BD3MXivFGnu7o%3D 10.1056/NEJM200104053441402 11287973 (Pubitemid 32267973)
2. M Yanada R Ohno T Naoe 2009 Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia Int J Hematol 89 3 13 1:CAS:528:DC%2BD1MXkvVWjtA%3D%3D 10.1007/s12185-008-0223-z 19093166
3. RA Larson RK Dodge CA Linker RM Stone BL Powell EJ Lee, et al. 1998 A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111 Blood 92 1556 1564 1:CAS:528:DyaK1cXls1Siu70%3D 9716583
4. J Takeuchi T Kyo K Naito H Sao M Takahashi S Miyawaki, et al. 2002 Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study Leukemia 16 1259 1266 1:CAS:528:DC%2BD38XkvFKrtr8%3D 10.1038/sj.leu.2402526 12094249
5. H Kantarjian D Thomas S O'Brien J Cortes F Giles S Jeha, et al. 2004 Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia Cancer 101 2788 2801 1:CAS:528:DC%2BD2MXivFOhuw%3D%3D 10.1002/cncr.20668 15481055 (Pubitemid 39603187)
6. X Thomas JM Boiron F Huguet H Dombret K Bradstock N Vey, et al. 2004 Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial J Clin Oncol 22 4075 4086 1:CAS:528:DC%2BD2cXpslOrsrg%3D 10.1200/JCO.2004.10.050 15353542 (Pubitemid 41185176)
7. JM Rowe G Buck AK Burnett R Chopra PH Wiernik SM Richards, et al. 2005 Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993 Blood 106 3760 3767 1:CAS:528:DC%2BD2MXht12ksbnI 10.1182/blood-2005-04-1623 16105981 (Pubitemid 41739010)
8. L Annino ML Vegna A Camera G Specchia G Visani G Fioritoni, et al. 2002 Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study Blood 99 863 871 1:CAS:528: DC%2BD38XhtValsb4%3D 10.1182/blood.V99.3.863 11806988 (Pubitemid 34525547)
9. K Tobinai K Takeyama F Arima K Aikawa T Kobayashi S Hanada, et al. 2007 Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004 Cancer Sci 98 1350 1357 1:CAS:528:DC%2BD2sXhtVaksrrO 10.1111/j.1349-7006.2007.00556.x 17640299 (Pubitemid 47241756)
10. AV Moorman CJ Harrison GA Buck SM Richards LM Secker-Walker M Martineau, et al. 2007 Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial Blood 109 3189 3197 1:CAS:528:DC%2BD2sXksFWitLc%3D 10.1182/blood-2006-10-051912 17170120 (Pubitemid 46572503)
11. V Pullarkat ML Slovak KJ Kopecky SJ Forman FR Appelbaum 2008 Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study Blood 111 2563 2572 1:CAS:528: DC%2BD1cXivFakt70%3D 10.1182/blood-2007-10-116186 18156492
12. RA Larson RK Dodge CP Burns EJ Lee RM Stone P Schulman, et al. 1995 A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811 Blood 85 2025 2037 1:CAS:528:DyaK2MXltVSrtbs%3D 7718875
13. JM Bennett D Catovsky MT Daniel G Flandrin DA Galton HR Gralnick, et al. 1976 Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group Br J Haematol 33 451 458 1:STN:280:DyaE2s%2FoslKisw%3D%3D 10.1111/j.1365-2141.1976.tb03563.x 188440
14. International System for Human Cytogenetic Nomenclature. In: Mitelman F, editor. An international system for human cytogenetic nomenclature. Basel, Switzerland: S Karger; 1995.
15. J Boos G Werber E Ahlke P Schulze-Westhoff U Nowak-Göttl G Würthwein, et al. 1996 Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations Eur J Cancer 32A 1544 1550 1:CAS:528:DyaK28XmtFWitLw%3D 10.1016/0959-8049(96)00131-1 8911116 (Pubitemid 26279122)
16. U Nowak-Göttl G Werber D Ziemann E Ahlke J Boos 1996 Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL Haematologica 81 127 131 8641640
17. M Schemper TL Smith 1996 A note on quantifying follow-up in studies of failure time Control Clin Trials 17 343 346 1:STN:280:DyaK2s%2FksVaktA%3D%3D 10.1016/0197-2456(96)00075-X 8889347 (Pubitemid 26342716)
18. EL Kaplan P Meier 1958 Non parametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
19. DR Cox 1972 Regression models and life-tables J R Stat Soc B 34 187 220
20. N Boissel MF Auclerc V Lhéritier Y Perel X Thomas T Leblanc, et al. 2003 Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials J Clin Oncol 21 774 780 10.1200/JCO.2003.02.053 12610173 (Pubitemid 46606434)
21. W Stock M La B Sanford CD Bloomfield JW Vardiman P Gaynon, et al. 2008 What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies Blood 112 1646 1654 1:CAS:528:DC%2BD1cXhtVylu77L 10.1182/blood-2008-01-130237 18502832
22. JM Storring MD Minden S Kao V Gupta AC Schuh AD Schimmer, et al. 2009 Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen Br J Haematol 146 76 85 10.1111/j.1365-2141.2009. 07712.x 19438471
23. F Huguet T Leguay E Raffoux X Thomas K Beldjord E Delabesse, et al. 2009 Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study J Clin Oncol 27 911 918 1:CAS:528:DC%2BD1MXjs1Kntrc%3D 10.1200/JCO.2008.18.6916 19124805
24. M Yanada I Jinnai J Takeuchi T Ueda S Miyawaki M Tsuzuki, et al. 2007 Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates Leuk Res 31 907 914 10.1016/j.leukres.2006.08.004 17005250 (Pubitemid 46856714)
25. D Hoelzer 1994 Treatment of acute lymphoblastic leukemia Semin Hematol 31 1 15 1:STN:280:DyaK2c7mslKisg%3D%3D 8122133
26. SL Berg SM Blaney M Devidas TA Lampkin A Murgo M Bernstein, et al. 2005 Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group J Clin Oncol 23 3376 3382 1:CAS:528:DC%2BD2MXlsVyiu7g%3D 10.1200/JCO.2005.03.426 15908649
27. DJ DeAngelo D Yu JL Johnson SE Coutre RM Stone AT Stopeck, et al. 2007 Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801 Blood 109 5136 5142 1:CAS:528:DC%2BD2sXmslOku7k%3D 10.1182/blood-2006-11-056754 17344466 (Pubitemid 46890527)
28. AH Goldstone SM Richards HM Lazarus MS Tallman G Buck AK Fielding, et al. 2008 In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) Blood 111 1827 1833 1:CAS:528:DC%2BD1cXisVeisr0%3D 10.1182/blood-2007-10-116582 18048644 (Pubitemid 351451489)
29. Cornelissen JJ, van der Holt B, Verhoef GE, van't Veer MB, van Oers MH, Schouten HC, et al. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood. 2009;113:1375-82.